AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF TESTOSTERONE AND CARDIOVASCULAR RISK

Endocr Pract. 2015 Sep;21(9):1066-73. doi: 10.4158/EP14434.PS.

Abstract

This document represents the official position of the American Association of Clinical Endocrinologists and the American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cardiovascular Diseases / chemically induced*
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control
  • Consensus*
  • Drug Labeling
  • Endocrinology*
  • Hormone Replacement Therapy / adverse effects*
  • Humans
  • Hypogonadism / complications
  • Hypogonadism / drug therapy
  • Male
  • Middle Aged
  • Risk Factors
  • Societies, Medical
  • Testosterone / adverse effects*
  • Testosterone / deficiency
  • Testosterone / therapeutic use
  • United States
  • United States Food and Drug Administration

Substances

  • Testosterone